InvestorsHub Logo

God_Father

04/15/21 6:32 PM

#99743 RE: rudyboy #99701

It's only been 10 days since the company dropped incredible news of finding that the mAbs produced by the company are directed towards parts of the virus that can't mutate out.

We have only begun to explore the possibilities here.

COLLEGE STATION, TX / ACCESSWIRE / April 5, 2021 / Enzolytics, Inc. (OTC PINK:ENZC) (or the "Company").
In a significant development, recent findings have revealed that the monoclonal antibodies being produced by the Company against targeted sites on the Coronavirus are directed against epitopes that exist conservatively on each of the variant strains of the virus from the UK, Brazil and South African.